Panduan Penulisan
Hubungan Karakteristik Lansia yang Divaksinasi Booster Pfizer Covid-19 Dengan Kejadian Ikutan Pasca Imunisasi di Wilayah Kerja Puskesmas Rajabasa Indah Kota Bandar Lampung
Sari
ABSTRACT
The elderly are one of priority groups for vaccine recipients after health worker. COVID-19 vaccination is an effort to break the chain of COVID-19 transmission of COVID-19. Vaccine booster aims to increase individual protection, because there is a decrease in antibodies after 6 months of receiving the primary dose. However, vaccine booster can cause Adverse Event Following Immunization (AEFI). Rajabasa Indah Health Center is a health service that provides Pfizer COVID-19 booster vaccinations. To know the correlation characteteristics of elderly who had been vaccinated Pfizer booster COVID-19 with adverse event following immuniation in the working ares of Rajabasa Indah Health Center, Bandar Lampung City, 2022. Quantitative study with an analytic approach using a cross-sectional and the instrument used is a questionnaire. Based on the results, there are correlation between monthly income (p=0,019<0,05) and comorbid history (p=0,048<0,05) over AEFI in elderly and there are no correlation between gender (p=0,956<0,05), age (p=0,380<0,05) and COVID-19 history (p=0,788<0,05) over AEFI at working area of Rajabasa Indah Health Center, Bandar Lampung City in 2022. There are correlation between monthly income and comorbid history over AEFI in elderly and there are no correlation between gender, age and COVID-19 history over AEFI at working area of Rajabasa Indah Health Center, Bandar Lampung City in 2022.
Keyword: Adverse Event Following Immunization, Booster, COVID-19, Elderly
ABSTRAK
Lanjut usia (lansia) menjadi salah satu kelompok prioritas penerima vaksin setelah tenaga kesehatan. Vaksinasi COVID-19 merupakan upaya untuk memutus rantai penularan COVID-19 Vaksinasi COVID-19 Dosis Lanjutan (booster) bertujuan untuk meningkatkan proteksi individu, karena terjadi penurunan antibodi setelah 6 bulan menerima vaksin dosis primer. Namun, pemberian vaksin dapat menimbulkan Kejadian Ikutan Pasca Imunisasi (KIPI). Puskesmas Rajabasa Indah merupakan layanan kesehatan yang melayani vaksinasi booster Pfizer COVID-19. Mengetahui hubungan karateristik lansia yang divaksinasi booster Pfizer COVID-19 dengan kejadian Kejadian Ikutan Pasca Imunisasi di wilayah kerja Puskesmas Rajabasa Indah Banadr Lampung tahun 2022. Penelitian kuantitatif yang bersifat analitik dengan menggunakan rancangan cross sectional dan instrument yang digunakan adalah kuesioner. Pengambilan sampel yang digunakan dengan menggunakan teknik total sampling dengan jumlah 124 responden. Berdasarkan hasil pada penelitian menunjukkan bahwa terdapat hubungan antara pendapatan (p=0,019<0,05) dan riwayat komorbid (p=0,048<0,05) terhadap KIPI pada lansia dan tidak ada hubungan antara jenis kelamin (p=0,956>0,05), usia (p=0,380>0,05) dan riwayat COVID-19 (p=0,788>0,05) terhadap KIPI di wilayah kerja Puskesmas Indah Kota Bandar Lampung tahun 2022. Terdapat hubungan antara pendapatan dan riwayat komorbid terhadap KIPI pada lansia dan tidak ada hubungan antara jenis kelamin, usia dan riwayat COVID-19 dengan kejadian KIPI pada lansia di wilayah kerja Puskesmas Rajabasa Indah Kota Bandar Lampung tahun 2022.
Kata Kunci: Kejadian Ikutan Pasca Imunisasi, Booster, COVID-19, Lansia.
Teks Lengkap:
Download ArtikelReferensi
Aditama, T. Y. (2021). Covid-19 Dalam Tulisan Prof. Tjandra. Lembaga Penerbit Badan Penelitian Dan Pengembangan Kesehatan (Lpb).
Arregocés-Castillo, L., Fernández-Niño, J., Rojas-Botero, M., Palacios-Clavijo, A., Galvis-Pedraza, M., Rincón-Medrano, L., Pinto-Álvarez, M., Ruiz-Gómez, F., & Trejo-Valdivia, B. (2022). Effectiveness Of Covid-19 Vaccines In Older Adults In Colombia: A Retrospective, Population-Based Study Of The Esperanza Cohort. The Lancet Healthy Longevity, 3(4), E242–E252. Https://Doi.Org/10.1016/S2666-7568(22)00035-6
Auster, O., Finkel, U., Dagan, N., Barda, N., Laufer, A., Balicer, R. D., & Ben-Shachar, S. (2022). Short-Term Adverse Events After The Third Dose Of The Bnt162b2 Mrna Covid-19 Vaccine In Adults 60 Years Or Older. Jama Network Open, 5(4), E227657. Https://Doi.Org/10.1001/Jamanetworkopen.2022.7657
Basri, A. H. (2021). Analisis Kejadian Ikutan Pasca Imunisasi (Kipi) Vaksin Covid-19 Sinovac Di Rumah Sakit Wirasakti Kupang Periode 20 Januari 2021 – 20 Februari 2021. Universitas Nusa Cendana.
Cahyono, E. A., & Darsini. (2022). Sikap Masyarakat Terhadap Program Vaksinasi Booster Covid-19 (Validitas Dan Reliabilitas Kuesioner Penelitian). Jurnal Pengembangan Ilmu Dan Praktik Kesehatan, 1(1), 1–21.
Dahlan, Andi Kasrida, Umrah, A. St., & Abeng, T. (2018). Kesehatan Lansia: Kajian Teori Gerontologi Dan Pendekatan Asuhan (Issue January 2018). Intimedia.Https://Www.Kemkes.Go.Id/Article/View/19070500004/Indonesia-Masuki-Periode-Aging-Population.Html
Dinas Kesehatan Kota Bandar Lampung. (2022). Rekapan Vaksinasi Sumber Kpc-Pen (15 November 2022 Pukul 14.30).
Fang, L., K, G., & R, M. (2020). Are Patients With Hypertension And Diabetes Mellitus At Increased Risk For Covid-19 Infection? Lancet Respir Med, 8(4), E21. Https://Doi.Org/10.1111/All.14238.Wan
Fortuna, D. F. (2022). Determinan Kesediaan Vaksinasi Covid-19 Pada Masyarakat Marginal Kecamaatna Manggala Kota Makassar. In Universitas Islam Negeri Alauddin Makassar (Issue 1). Universitas Islam Negeri Alauddin Makassar.
Ganesan, S., Al Ketbi, L. M. B., Al Kaabi, N., Al Mansoori, M., Al Maskari, N. N., Al Shamsi, M. S., Alderei, A. S., El Eissaee, H. N., Al Ketbi, R. M., Al Shamsi, N. S., Saleh, K. M., Al Blooshi, A. F., Cantarutti, F. M., Warren, K., Ahamed, F., & Zaher, W. (2022). Vaccine Side Effects Following Covid-19 Vaccination Among The Residents Of The Uae—An Observational Study. Frontiers In Public Health, 10(May), 1–9. Https://Doi.Org/10.3389/Fpubh.2022.876336
Gustafson, C. E., Kim, C., Weyand, C. M., & Goronzy, J. J. (2020). Influence Of Immune Aging On Vaccine Responses. Journal Of Allergy And Clinical Immunology, 145(5), 1309–1321.Https://Doi.Org/10.1016/J.Jaci.2020.03.017
Hause, A. M., Baggs, J., Marquez, P., Myers, T. R., Su, J. R., Blanc, P. G., Baumblatt, J. A. G., Woo, E. J., Gee, J., Shimabukuro, T. T., & Shay, D. K. (2022). Safety Monitoring Of Covid-19 Vaccine Booster Doses Among Adults — United States, September 22, 2021–February 6, 2022. Mmwr Recommendations And Reports, 71(7), 249–254. Https://Doi.Org/10.15585/Mmwr.Mm7107e1
Hendarto, M. H. (2022). Hubungan Antara Jenis Kelamin, Riwayat Alergi Dan Komorbid Dengan Kejadain Ikutan Pasca Imunisasi (Kipi) Pada Mahasiswa Preklinik Fakultas Kedokteran Uin Jakarta Yang Mendapatkan Vaksinasi Booster Bnt162b2. Universitas Lampung.
Hulu, V. T., Lubis, A., & Mahyuni, S. (2022). Gambaran Karateristik Kejadian Ikutan Paca Imunisasi Vaksin Covid-19 Di Puskesmas Namorambe Tahun 2021. Jurnal Kedokteran Ibnu Nafis, 11(1), 37–48. Https://Jurnal.Fk.Uisu.Ac.Id/Index.Php/Ibnunafis
Jayadevan, R., Shenoy, R., & Ts, A. (2021). Survey Of Symptoms Following Covid-19 Vaccination In India. Medrxiv , 1–9. Https://Doi.Org/10.1101/2021.02.08.21251366
Joshi, R. K., Muralidharan, C. G., Gulati, D. S., Mopagar, V., Dev, J. K., Kuthe, S., Rather, A. A., & Sahoo, A. K. (2021). Higher Incidence Of Reported Adverse Events Following Immunisation (Aefi) After First Dose Of Covid-19 Vaccine Among Previously Infected Health Care Workers. Medical Journal Armed Forces India, 77, S505–S507. Https://Doi.Org/10.1016/J.Mjafi.2021.05.011
Kemenkes Ri. (2014). Buku Ajar Imunisasi. In Kementerian Kesehatan Ri. Pusat Pendidikan Dan Pelatihan Tenaga Kesehatan.Https://Www.Kemkes.Go.Id/Article/View/19093000001/PenyakitJantungPenyebab-Kematian-Terbanyak-Ke-2-Di-Indonesia.Html
Kemenkes Ri. (2020a). Hindari Lansia Dari Covid-19. Kemenkes Ri. Http://Www.Padk.Kemkes.Go.Id/Article/Read/2020/04/23/21/Hindari-Lansia-Dari-Covid-19.Html
Kemenkes Ri. (2020b). Pedoman Pencegahan Dan Pengendalian Coronavirus Disease (Covid-19) (Vol. 4) [Kementrian Kesehatan Ri].Https://Doi.Org/10.33654/Math.V4i0.299
Kemenkes Ri. (2021a). Buku Saku Tanya Jawab Seputar Vaksinasi Covid-19 (1st Ed.). Kementrian Kesehatan Republik Indonesia.
Kemenkes Ri. (2021b). Keputusan Menteri Kesehatan Republik Indonesia Nomor Hk.01.07/Menkes/4638/2021 Tentang Petunjuk Teknis Pelaksanaan Vaksinasi Dalam Rangka Penanggulangan Pandemi Corona Virus Disease 2019 (Covid-19). Jurnalrespirologi.Org, 2, 1–4. Http://Www.Jurnalrespirologi.Org/Index.Php/Jri/Article/View/101
Kemenkes Ri. (2021c). Pedoman Pengelolaan Vaksin Di Fasyankes. In Kemenkes Ri. Kementrian Kesehatan Ri.
Kemenkes Ri. (2021d). Question ( Faq ) Pelaksanaan Vaksinasi Covid-19. Kemenkes Ri, 2(1), 1–16. Kesmas.Kemkes.Go.Id
Kemenkes Ri. (2022a). Surat Edaran No. Hk.02.02/Ii/252/2022 Tentang Vaksinasi Covid-19 Dosis Lanjutan (Booster). Kementerian Kesehatan Ri, Januari, 7. Https://Www.Kemkes.Go.Id/Article/View/19031800003/CegahPenyalahgunaanNarkobaKemenkesAjakTerapkanGermas.Html%0ahttps://Www.Depkes.Go.Id/Article/View/18030500005/WaspadaiPeningkatanPenyakitMenular.Html%0ahttp://Www.Depkes.Go.Id/Article/View/1707070
Kemenkes Ri. (2022b). Vaksinasi Covid-19 Nasional. Kemenkes Ri.Https://Vaksin.Kemkes.Go.Id/#/Vaccines
Kemenkes Ri. (2022c). Vaksinasi Covid-19 Provinsi. Kemenkes Ri.Https://Vaksin.Kemkes.Go.Id/#/Provinces
Kementerian Kesehatan Ri. (2022). Penambahan Regimen Booster. 1(1), 2. Https://Www.Kemkes.Go.Id/Article/View/19093000001/Penyakit-Jantung-Penyebab-Kematian-Terbanyak-Ke-2-Di-Indonesia.Html
Kesehatan, K. (2022). Penyesuaian Pelaksanaan Vaksinasi Covid-19 Dosis Lanjutan (Booster) Bagi Masyarakat Umum. Kementerian Kesehatan Ri, 1(1), 1. Https://Jdih.Kemkes.Go.Id/
Klein, S. L., & Pekosz, A. (2014). Sex-Based Biology And The Rational Design Of Influenza Vaccination Strategies. Journal Of Infectious Diseases, 209(Suppl 3), 114–119. Https://Doi.Org/10.1093/Infdis/Jiu066
Koesnoe, S. (2021). Teknis Pelaksanaan Vaksin Covid Dan Antisipasi Kipi. Perhimpunan Dokter Spesialis Penyakit Dalam Indonesia, 1–65.
Masturoh, I., & Temesvari, N. A. (2018). Metode Penelitian Kesehatan. Kementrian Kesehatan Ri.
Menni, C., Klaser, K., May, A., Polidori, L., Capdevila, J., Louca, P., Sudre, C. H., Nguyen, L. H., Drew, D. A., Merino, J., Hu, C., Selvachandran, Somesh, Antonelli, Michela, Murray, B., Canas, L. S., Molteni, E., Graham, M. S., … Spector, T. D. (2021). Vaccine Side-Effects And Sars-Cov-2 Infection After Vaccination In Users Of The Covid Symptom Study App In The Uk: A Prospective Observational Study. The Lancet Infectious Diseases, 21(7), 939–949. Https://Doi.Org/10.1016/S1473-3099(21)00224-3
Misnaniarti. (2017). Analisis Situasi Penduduklanjut Usia Dan Upaya Peningkatan Kesejahteraan Sosial Di Indonesia. Jurnal Ilmu Kesehatan Masyarakat, 8(2), 6773.Https://Doi.Org/10.26553/Jikm.2017.8.2.67-73
Miyaji, K. T., Yuji, L., Itto, U., Caue, L., Caroline, A., Sales, R., Hiratsuka, M., Leonel, F. C., Higa-Taniguchi, K. T., Melo, C., Lopes, M. H., Marli, A., & Sartori, C. (2022). Original Article. 56(64), 4–11.
Notoatmodjo, S. (2018). Metodolgi Penelitian Kesehatan. In Rineka Cipta (Vol. 1, P. 243).
Ogar, C. K., Quick, J., Gilbert, H. N., Vreman, R. A., Mantel-Teeuwisse, A. K., & Mugunga, J. C. (2023). Adverse Events To Sars-Cov-2 (Covid-19) Vaccines And Policy Considerations That Inform The Funding Of Safety Surveillance In Low- And Middle-Income Countries: A Mixed Methods Study. Drug Safety, 46(4), 357–370. Https://Doi.Org/10.1007/S40264-023-01279-3
Pdpi. (2022). Panduan Vaksinasi Untuk Penyakit Paru Dan Pernapasan Pada Orang Dewasa (F. Isbaniah, F. Yunus, & A. D. Susanto (Eds.)). Perhimpunan Dokter Paru Indonesia (Pdpi).
Pdpi, Perki, Papdi, Perdatin, & Idai. (2022). Cedera Miokardium Pada Infeksi Covid-19. In Pedoman Tatalaksana Covid-19 Edisi 4 (4th Ed.). Pdpi, Perki, Papdi, Perdatin, Idai. Https://Www.Papdi.Or.Id/Pdfs/1153/Buku Tatalaksana Covid-19 5 Op Edisi 4 Jan 2022.Pdf
Pemenkes Ri. (2016). Rencana Aksi Nasional Kesehatan Lanjut Usia Tahun 2016- 2019. 1–96.
Pergemi. (2022). Survei Kondisi Kesehatan Dan Kesejahteraan Lansia Di Indonesia. Survei Pergemi. Https://Pergemi.Id/
Qu, J. M., Cao, B., & Chen, R. C. (2020). Covid-19: The Essentials Of Prevention And Treatment. Elsevier. Www.Elsevier.Com/Permissions
Rakasiwi, L. S., & Kautsar, A. (2021). Pengaruh Faktor Demografi Dan Sosial Ekonomi Terhadap Status Kesehatan Individu Di Indonesia. Kajian Ekonomi Dan Keuangan, 5(2), 146157.Https://Doi.Org/10.31685/Kek.V5i2.1008
Remlabeevi, A., Mathew, T., Nair, G. S. H., Nair, G. L. R., & Alex, M. R. (2021). Adverse Events And Their Association With Comorbidities After First And Second Doses Of Covishield Vaccination Among Healthcare Workers Of Government Owned Medical Colleges In Kerala. Medrxiv, 2021.05.19.21257317. Https://Www.Medrxiv.Org/Content/10.1101/2021.05.19.21257317v1%0ahttps://Www.Medrxiv.Org/Content/10.1101/2021.05.19.21257317v1.Abstract
Saptutyningsih, E., & Setyaningrum, E. (2019). Penelitian Kuantitatif: Metode Dan Alat Analisis. Gosyen.
Satgas Penanganan Covid-19. (2022a). Peta Sebaran. Satgas Penanganan Covid-19. Https://Covid19.Go.Id/Id/Peta-Sebaran
Satgas Penanganan Covid-19. (2022b). Situasi Covid-19 Di Indonesia (Update Per 28 November 2022). Satgas Penanganan Covid-19. Https://Covid19.Go.Id/Storage/App/Media/PenanganaCovid19/2022/November/20221128Update Percepatan Penanganan Covid-19 Di Indonesia.Pdf
Seldadyo, H., Ali, S., Turana, Y., Budiyanta, N. E., Suci, E. S. T., & Marditia, P. P. R. (2022). Kesejahteraan Warga Lanjut Usia. Universitas Katolik Indonesia Atma Jaya.
Sovitriana, R. (2020). Kajian Gender Dalam Tinjauan Psikologi. In Angewandte Chemie International Edition, 6(11), 951–952. (Vol. 13, Issue April). Uwais Inspirasi Indonesia.
Sugiyono. (2021). Metode Penelitian Kuantitatif, Kualitatif Dan R&D. Alfabeta.
Susilo, A., Rumende, C. M., Pitoyo, C. W., Santoso, W. D., Yulianti, M., Herikurniawan, Sinto, R., Singh, G., Nainggolan, L., Nelwan, E. J., Khie, L., Chen, Widhani, A., Wijaya, E., Wicaksana, B., Maksum, M., Annisa, F., Jasirwan, C. O., & Yunihastuti, E. (2020). Coronavirus Disease 2019: Tinjauan Literatur Terkini. Jurnal Penyakit Dalam Indonesia, 7(2), 45–61. Https://Doi.Org/10.25104/Transla.V22i2.1682
Tissot, N., Brunel, A. S., Bozon, F., Rosolen, B., Chirouze, C., & Bouiller, K. (2021). Patients With History Of Covid-19 Had More Side Effects After The First Dose Of Covid-19 Vaccine. Vaccine, 39(36), 5087–5090. Https://Doi.Org/10.1016/J.Vaccine.2021.07.047
Urakawa, R., Isomura, E. T., Matsunaga, K., Kubota, K., & Ike, M. (2022). Impact Of Age, Sex And Medical History On Adverse Reactions To The First And Second Dose Of Bnt162b2 Mrna Covid-19 Vaccine In Japan: A Cross-Sectional Study. Bmc Infectious Diseases, 22(1), 18.Https://Doi.Org/10.1186/S12879-022-07175-Y
Wardani, S. (2021). Gambaran Karakteristik Epidemiologi Pada Penyintas Covid-19 Dengan Komorbid Di Kecamatan Nuha Kabupaten Luwu Timur Tahun 2021. In Universitas Islam Negeri Alauddin Makassar (Issue 1). Universitas Islam Negeri Alauddin Makassar.
Who. (2020). Coronavirus Disease (Covid-19). Who. Https://Www.Who.Int/Health-Topics/Coronavirus#Tab=Tab_3
Who. (2021). Q&A On Covid-19 Variants.Https://Www.Who.Int/Southeastasia/Outbreaks-And-Emergencies/Covid19/Questions/Variants-Q-A
Who. (2022a). Global Covid-19 Vaccination Strategy In A Changing World: July 2022 Update. Global Covid-19 Vaccination Strategy In A Changing World: July 2022 Update, July. Https://Www.Who.Int/Publications/M/Item/Global-Covid-19-VaccinationStrategyInAChanging-World--July-2022-Update
Who. (2022b). Tanya Jawab: Bagaimana Cara Kerja Vaksin? Who.Https://Www.Who.Int/Indonesia/News/NovelCoronavirus/Qa/Qa-Cara-Kerja-Vaksin
Who. (2022c). Who Coronavirus (Covid-19) Dashboard With Vaccination Data. Who.
Yulyani, V., Hasbie, N. F., Farich, A., & Valentine, A. (2022). Hubungan Status Demografi, Komorbid Dengan Kipi Post Vaksin Covid-19 Pada Tenaga Kesehatan. Jurnal Ilmiah Kesehatan Sandi Husada, 11, 153160.Https://Doi.Org/10.35816/Jiskh.V11i1.725
Zhou, F. Et Al. (2020). Clinical Course And Risk Factors For Mortality Of Adult Inpatients With Covid-19 In Wuhan, China: A Retrospective Cohort Study. The Lancet, 395(10229), 10541062.Https://Doi.Org/10.1016/S0140-6736(20)30566-3
Zhu, J. S., Zhang, M. X., Chien, C. W., Yang, W. Y., Shi, G. F., Qiu, S., Tung, T. H., & Chen, H. X. (2021). Sex Differences In Adverse Reactions To An Inactivated Sars-Cov-2 Vaccine Among Medical Staff In China. Frontiers In Medicine, 8(September), 1–9. Https://Doi.Org/10.3389/Fmed.2021.731593
DOI: https://doi.org/10.33024/mahesa.v3i6.10444
Refbacks
- Saat ini tidak ada refbacks.
Publisher: Universitas Malahayati Lampung
Semua artikel dapat digunakan dibawah lisensi Creative Commons Attribution-ShareAlike 4.0 International License
kostenlose besucherzähler